首页> 中文期刊> 《中国医药导报》 >止嗽汤加减联合阿奇霉素治疗小儿支原体肺炎22例观察

止嗽汤加减联合阿奇霉素治疗小儿支原体肺炎22例观察

         

摘要

Objective To observe the therapeutic efficacy of Cough Decoction combined with Azithromycin in the treatment of mycoplasma pneumonia (MPP) of children. Methods 45 cases of children with MPP were randomly assigned into treatment group and control group. Patients in the treatment group were treated with Cough Decoction combined Azithromycin. Patients in the control group were only given Azithromycin. Treatment efficacies of the two groups were compared. Results Clinical score of the treatment group and control group were (0.51±0.14) scores and (0.90±0.11) scores respectively, the corresponding effective rates were 95.45% and 73.91%, incidence of adverse events were 9.09% and 60.87% respectively, and the differences were significant (P < 0.05). Conclusion Cough Decoction combined with Azithromycin can alleviate the clinical manifestations, enhance clinical efficacy and reduce adverse reactions in the treatment of MPP, so it is worthy of clinical application.%目的 观察止嗽汤加减联合阿奇霉素治疗小儿支原体肺炎(MPP)的疗效.方法 将45例MPP患儿随机分为治疗组(22例)和对照组(23例),治疗组给予止嗽汤加减联合阿奇霉素治疗,对照组单纯给予阿奇霉素治疗,并观察对比两组的临床疗效.结果 治疗组和对照组治疗2周后临床评分分别为(0.51±0.14)分和(0.90±0.11)分,有效率分别为95.45%、73.91%,不良反应发生率分别为9.09%和60.87%,两组三项指标比较,差异均有统计学意义(均P<0.05).结论 采用止嗽汤加减联合阿奇霉素治疗MPP,具有缓解临床表现、增强临床疗效、减少不良反应少等优势,值得推广.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号